Nationwide Fund Advisors’s SYNAGEVA BIOPHARMA CORP COM STK (DE) GEVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q2
Sell
2015
Q1
$1.66M Buy
2014
Q4
$1.5M Sell
2014
Q3
$1.13M Sell
2014
Q2
$1.72M Buy
2014
Q1
$1.27M Buy
2013
Q4
$962K Buy
2013
Q3
$858K Sell
2013
Q2
$1.33M Buy